Company facts
- Headquarters
- New York, New York
- Most recent report
- 10-Q, filed Nov 5, 2026
- Incorporated
- Delaware
- Filings on record
- 19,262+ filings
- On EDGAR
- CIK 895421
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 4
News 7
Prospectuses and Registrations 8 of 18,876
- 424B2 Prospectus supplement for an offering Nov 9, 2026
- 424B2 Prospectus supplement for an offering Nov 9, 2026
- 424B2 Prospectus supplement for an offering Nov 9, 2026
- 424B2 Prospectus supplement for an offering Nov 9, 2026
- 424B2 Prospectus supplement for an offering Nov 9, 2026
- 424B2 Prospectus supplement for an offering Nov 9, 2026
- 424B2 Prospectus supplement for an offering Nov 9, 2026
- 424B2 Prospectus supplement for an offering Nov 9, 2026
Proxies 3
Ownership 8 of 365
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 6, 2026
- SCHEDULE 13G Large holder reported a passive stake Nov 6, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 6, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 6, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Nov 6, 2026
- 144 Notice of a proposed sale of restricted stock Nov 6, 2026
- 4 Insider reported a trade Nov 2, 2026
- 144 Notice of a proposed sale of restricted stock Oct 16, 2026
Other 7
- N-PX Record of how a fund voted its shares Aug 17, 2026
- 11-K Employee stock plan report Jun 25, 2026
- EFFECT Notice that a registration became effective Apr 8, 2026
- ARS Annual report sent to shareholders Apr 2, 2026
- 424B8 Apr 1, 2026
- CORRESP Reply to SEC staff Mar 30, 2026
- UPLOAD Comment letter from SEC staff Mar 9, 2026
What to read: Sep 2026 10-Q
SECSift found 5 of 6 sections worth reading, with 2 positive, 10 notable, and 1 negative flags.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Full MD&A with segment results, credit provisions, and balance sheet details.NotableBalance Sheet
Balance sheet details, liquidity resources, borrowings, and capital actions with specific numbers.Off-Balance Sheet Arrangements
Dense regulatory capital, TLAC, credit risk, and VaR data with period-over-period changes.Notable- Firm early-adopted final eSLR rule Jan 1, 2026; SLR required ratio dropped to 3.5% from 5.0% at Dec 2025.
- Basel III Proposal and G-SIB Surcharge Proposal issued March 19, 2026; firm evaluating impacts on capital requirements.
- Period-end Management VaR rose to $70M at Sept 30, 2026, from $54M at June 30, 2026, due to higher equity exposure and volatility.
- Total ACL for loans and lending commitments rose to $2.1B at Sept 30, 2026, from $1.9B at Dec 2025, driven by corporate and CRE provisions.
Balance Sheet
Loan book grew 13% to $315B; credit quality details and legal contingencies need attention.Consolidated VIE Assets and Liabilities by Balance Sheet Caption
Large VIE exposure, new $20B buyback, and regulatory capital changes.
What changed: Sep 2026 vs. Jun 2026
About 3% of MS's Sep 2026 10-Q is new information. 30 paragraphs were added, 356 changed, and 38 removed. Below are the most important lines SECSift identified.
Changed
- Nonaccrual loans fell to $829 million from $1,007 million, mainly due to a drop in corporate nonaccruals to $34 million from $146 million.
- ACL for loans to nonaccrual HFI loans rose to 150.1% from 123.9%, meaning the allowance covers a larger share of nonaccrual loans.
- Institutional Securities nonaccrual loans fell to 0.4% from 0.7% at Jun 30, 2026.
- SLR required ratio dropped to 3.5% from 5.0% at Sep 30, 2026.
- SCB now stays at 4.3% through Dec 31, 2027, not Oct 1, 2027.
- Final rules adopted Sep 30, 2026 replace earlier proposals on stress testing and SCB.
- LCR rose to 133% for the three months ended Sep 30, 2026 from 129% for the three months ended Jun 30, 2026.
Everything here comes from Morgan Stanley's own filings on SEC EDGAR. The filing list is rechecked every hour. SECSift analysis was completed on Nov 5, 2026, from the 10-Q for Sep 2026.